NTRA Q4 2020 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena

NTRANatera, Inc.

$29B

Q4 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$112M+35.0% YoY

Gross Profit

$52M46.7% margin

Operating Income

-$74M-65.8% margin

Net Income

-$76M-68.0% margin

EPS (Diluted)

$-0.94

QoQ Revenue Growth

+14.5%

Cash Flow

Operating Cash Flow

-$73M

Free Cash Flow

-$81M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$932M

Total Liabilities

$446M

Stockholders' Equity

$486M

Cash & Equivalents

$49M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$112M	$83M	+35.0%
Gross Profit	$52M	$39M	+35.4%
Operating Income	-$74M	-$35M	-112.5%
Net Income	-$76M	-$35M	-117.2%

Revenue Segments

Product

$106M95%

Licensing And Other

$6M5%

Geographic Segments

U

$105M96%

Other Geographic Areas

$3M3%

Americas Excluding Us

$885,0001%